1. Home
  2. SIFY vs BDSX Comparison

SIFY vs BDSX Comparison

Compare SIFY & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIFY
  • BDSX
  • Stock Information
  • Founded
  • SIFY 1995
  • BDSX 2005
  • Country
  • SIFY India
  • BDSX United States
  • Employees
  • SIFY N/A
  • BDSX N/A
  • Industry
  • SIFY Computer Software: Programming Data Processing
  • BDSX Precision Instruments
  • Sector
  • SIFY Technology
  • BDSX Health Care
  • Exchange
  • SIFY Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • SIFY 232.6M
  • BDSX 189.1M
  • IPO Year
  • SIFY 1999
  • BDSX 2020
  • Fundamental
  • Price
  • SIFY $3.29
  • BDSX $1.41
  • Analyst Decision
  • SIFY
  • BDSX Strong Buy
  • Analyst Count
  • SIFY 0
  • BDSX 4
  • Target Price
  • SIFY N/A
  • BDSX $3.08
  • AVG Volume (30 Days)
  • SIFY 79.8K
  • BDSX 648.1K
  • Earning Date
  • SIFY 01-16-2025
  • BDSX 11-01-2024
  • Dividend Yield
  • SIFY N/A
  • BDSX N/A
  • EPS Growth
  • SIFY N/A
  • BDSX N/A
  • EPS
  • SIFY N/A
  • BDSX N/A
  • Revenue
  • SIFY $443,027,157.00
  • BDSX $65,562,000.00
  • Revenue This Year
  • SIFY N/A
  • BDSX $46.97
  • Revenue Next Year
  • SIFY $12.52
  • BDSX $30.43
  • P/E Ratio
  • SIFY $60.04
  • BDSX N/A
  • Revenue Growth
  • SIFY 5.85
  • BDSX 48.92
  • 52 Week Low
  • SIFY $1.80
  • BDSX $1.11
  • 52 Week High
  • SIFY $12.30
  • BDSX $2.21
  • Technical
  • Relative Strength Index (RSI)
  • SIFY 48.05
  • BDSX 52.96
  • Support Level
  • SIFY $3.06
  • BDSX $1.24
  • Resistance Level
  • SIFY $3.64
  • BDSX $1.39
  • Average True Range (ATR)
  • SIFY 0.20
  • BDSX 0.09
  • MACD
  • SIFY -0.03
  • BDSX 0.01
  • Stochastic Oscillator
  • SIFY 22.22
  • BDSX 69.81

About SIFY Sify Technologies Limited

Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: